CT26 Cells
USD$450.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | CT26 is a widely utilized murine colon carcinoma cell line derived from BALB/c mice. These cells are characterized by their epithelial-like morphology and have been extensively used in cancer research, particularly in studies focusing on tumor immunology and the development of cancer therapies. The CT26 cell line is valuable due to its high tumorigenic potential and ability to form tumors when implanted in syngeneic mice, making it an excellent model for investigating the mechanisms of tumor growth and metastasis in a controlled environment. Research involving CT26 cells has provided critical insights into the immune system's response to tumors, aiding in the development of novel immunotherapeutic approaches. These cells are often used in conjunction with immunomodulatory agents to assess the efficacy of potential treatments and to study the interactions between cancer cells and the immune system. The CT26 cell line's compatibility with various genetic manipulation techniques further enhances its utility in exploring the molecular underpinnings of cancer and testing new therapeutic strategies. Overall, the CT26 cell line is a cornerstone in preclinical cancer research, contributing to the understanding of colorectal cancer biology and the advancement of therapeutic interventions. Its relevance in immunotherapy studies underscores its importance in the ongoing efforts to develop effective cancer treatments. Due to its robust nature and well-documented characteristics, CT26 continues to be a preferred model in oncology research. |
|---|---|
| Organism | Mouse |
| Tissue | Colon |
| Disease | Adenocarcinoma |
| Synonyms | CT-26, CT 26, Colon Tumor 26 |
Characteristics
| Breed/Subspecies | BALB/c |
|---|---|
| Age | Unspecified |
| Gender | Female |
| Growth properties | Adherent |
Regulatory Data
| Citation | CT26 (Cytion catalog number 305229) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_7254 |
Biomolecular Data
| Tumorigenic | Yes, in BALB/c mice |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305229-040625 | Certificate of Analysis | 21. Jul. 2025 | 305229 |
| 305229-200624 | Certificate of Analysis | 23. May. 2025 | 305229 |